Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Explore methods to stay financially stable mid-month, including disciplined review and targeted adjustments that protect your budget.
23,913 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
XRP is testing critical levels near $1.40 this week as traders watch for a breakout. Momentum is building, but regula...
As Vivid Seats reports Q4 2025 results, investors face a pivotal moment. This article breaks down revenue drivers, ma...
Institutional demand is reshaping crypto markets as investors lean on options to define risk on large Bitcoin positio...
TAO jumps more than 10% in a single session as Bitcoin targets $72,000. The move sets the tone for a weekend of volat...
Ethereum’s chart flashed a buy signal after months of pressure, with prices hovering near the $2,320–$2,360 range as ...
Uber stock jumps after AI chatter linked to Nvidia sparks a rally as the company details a 2027 robotaxi rollout and ...
PI traders faced renewed selling pressure this week, driving PI below key thresholds. The market now tests 0.15 suppo...
Bitcoin slips below the $70,000 mark as oil prices surge and geopolitics roil markets. Analysts warn the crypto may c...
Evernorth Holdings, a Ripple-backed company holding 473 million XRP, filed an S-4 to go public on Nasdaq through a $1...
A major move by a prominent asset manager reveals how large portfolios tweak biotech bets. Learn what the trim means ...
BNB rose on March 24, 2026, as volume surged and traders weigh whether it can reach the monthly target, boosted by st...